|
Addgene inc
rat synaptotagmin 1 c2ab domain residues 271 421 ![]() Rat Synaptotagmin 1 C2ab Domain Residues 271 421, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/plv-AcGFP-SOD1+(G93A)+(Plasmid+%2327142)/10__7554_slash_elife__57154-435-29-59 Average 91 stars, based on 1 article reviews
rat synaptotagmin 1 c2ab domain residues 271 421 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
sod1 g93a transgenic mice ![]() Sod1 G93a Transgenic Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/g93a+mice+sod1/pmc12603167-458-0-15 Average 86 stars, based on 1 article reviews
sod1 g93a transgenic mice - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
KU Leuven
sections of spinal cord of sod1 g93a mice ![]() Sections Of Spinal Cord Of Sod1 G93a Mice, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/sod1+g93a+mice/pmc06572738-417-28-20 Average 90 stars, based on 1 article reviews
sections of spinal cord of sod1 g93a mice - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Lemmens Inc
mutant sod1 ![]() Mutant Sod1, supplied by Lemmens Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/sod1+g93a/pmc06199948-96-18-37 Average 90 stars, based on 1 article reviews
mutant sod1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
mice overexpressing human superoxide dismutase 1 (wild type, g93a and g85r mutations) ![]() Mice Overexpressing Human Superoxide Dismutase 1 (Wild Type, G93a And G85r Mutations), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/hsod1+g93a+mice/pmc04175586-112-0-15 Average 90 stars, based on 1 article reviews
mice overexpressing human superoxide dismutase 1 (wild type, g93a and g85r mutations) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Charles River Laboratories
sod1-g93a hdac4fl/fl mice ![]() Sod1 G93a Hdac4fl/Fl Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/transgenic+g93a+sod1+mice/pm36613534-218-25-6 Average 90 stars, based on 1 article reviews
sod1-g93a hdac4fl/fl mice - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
g93 a h1 high-expressor strain ![]() G93 A H1 High Expressor Strain, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/g93+a+h1+high+expressor+strain/pmc03259267-324-12-17 Average 90 stars, based on 1 article reviews
g93 a h1 high-expressor strain - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Bedford VA Research Corporation
transgenic fragment r6/2 mice ![]() Transgenic Fragment R6/2 Mice, supplied by Bedford VA Research Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/g93a+sod1+mice/pmc02893277-118-0-18 Average 90 stars, based on 1 article reviews
transgenic fragment r6/2 mice - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
AAALAC International Inc
msod1 g93a mice ![]() Msod1 G93a Mice, supplied by AAALAC International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/msod1+g93a+mice/pmc03897268-105-0-14 Average 90 stars, based on 1 article reviews
msod1 g93a mice - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Rotem Industries
altered axonal localization with sod1 g93a expression ![]() Altered Axonal Localization With Sod1 G93a Expression, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/embryonic+spinal+motor+neurons++mouse++with+expression+of+sod1+g93a/pmc05985154-182-102-88 Average 90 stars, based on 1 article reviews
altered axonal localization with sod1 g93a expression - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Harlan UK Ltd
murine sod1 g93a transgenic mouse model ![]() Murine Sod1 G93a Transgenic Mouse Model, supplied by Harlan UK Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/murine+sod1+g93a+transgenic+mouse+model/pmc06672214-598-0-20 Average 90 stars, based on 1 article reviews
murine sod1 g93a transgenic mouse model - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Philips Healthcare
sod1 g93a mice ![]() Sod1 G93a Mice, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/g93a/sod+g93a+mice/pmc05873384-44-21-24 Average 90 stars, based on 1 article reviews
sod1 g93a mice - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: eLife
Article Title: Ca2+-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4,5-bisphosphate-containing membranes
doi: 10.7554/elife.57154
Figure Lengend Snippet: Figure 5. Analysis of interactions between Syt1 C2AB* and SNARE complexes anchored on nanodiscs using FRET. (A) Diagrams illustrating NDs, cisSC- NDs and transSC-NDs. Syntaxin-1 is in yellow, SNAP-25 in green and synaptobrevin in red. Although we used full-length syntaxin-1 to make the nanodisc-anchored SNARE complexes, the N-terminal region preceding the SNARE motif of syntaxin-1 is not shown for simplicity. (B) Fluorescence emission spectra of C2AB* (labeled with Alexa488 at residue 346) in the presence of increasing concentrations of cisSC-NDs (15% PS, 5% Rho-PE), in Figure 5 continued on next page
Article Snippet: Key resources table Reagent type (species) or resource Designation Source or reference Identifiers Additional information Recombinant DNA reagent pGEX-KG-GSTSyt1_C2B Brewer et al., 2015 Protein expression plasmid for E. coli (
Techniques: Fluorescence, Labeling, Residue
Journal: EMBO Molecular Medicine
Article Title: Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy
doi: 10.1038/s44321-025-00323-2
Figure Lengend Snippet: ( A ) Effects of ISO (5 to 150 μM) on the egg laying rate, egg hatching rate (L1), L4 development rate, and the adulthood rate (Adult day 1) in the WT N2 nematodes. Toxicity tests revealed a safe concentration range of ISO between 0 and 75 μM ( n = 5; 10 worms for each biological repeats). ( B ) Representative images showing the LGG-1 and DCT-1 co-localization in DMSO or ISO treatment group on adult day 1. unc119 + neurons are marked with white dotted borders. Scale bar, 5 μm. ( C , D ) Statistical results of mt-Rosella ( C ) and LGG-1/DCT-1 ( D ) transgenic worms showed that 15 μM ISO activated neuronal mitophagy ( n = 30 neurons from 30 worms for each group). ( E ) UV-killed OP50 experiment showing that the protective effect of ISO on the motility of SOD1 G93A worms was independent of microbial metabolism ( n = 20 worms for each group). ( F ) Effect of ISO on pharyngeal pumping speed from adult day 2 to day 14 in WT (N2) and SOD1 G93A worms. The results showed that ISO did not restrict the nematode diet ( n = 30 worms for each group). Data are presented as the mean ± SD. Exact P values are reported in Appendix Table . One-way ANOVA followed by Dunnett’s multiple comparisons test in ( A , C , D , F ). Two-way ANOVA followed by Tukey’s multiple comparisons test in ( E ).
Article Snippet:
Techniques: Concentration Assay, Transgenic Assay
Journal: EMBO Molecular Medicine
Article Title: Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy
doi: 10.1038/s44321-025-00323-2
Figure Lengend Snippet: ( A ) A representative image and schematic of unc-25 promoter expression in 26 GABAergic neurons, including 19 D-type MNs in the ventral cord (blue), 4 RMEs (purple), one AVL (red), and one RIS (green) in the head, and one DVB (red) in the tail. Scale bar, 100 μm. ( B ) Representative images showing the co-localization of LGG-1::DsRed and DCT-1::BFP in D-type MNs of N2 or SOD1 G93A transgenic worms. unc25 + D-type motor neurons are marked with white arrows. Scale bar, 1 μm. ( C ) Quantification of ( B ) showed lower basal mitophagy level in SOD1 G93A transgenic worms MNs than WT. ISO (15 μM) treatment induced mitophagy in MNs of SOD1 G93A transgenic worms. n = 30 D-type MNs from 30 worms for each group. ( D – I ) ISO treatment improved ALS-related phenotypes in SOD1 G93A worms, including ( D ) swimming ability, ( E ) paralysis, ( F , G ) MN loss (white square in ( F )), scale bar, 100 μm, ( H ) MN degeneration defined by loss of connections between MNs (red arrows in ( F )), and ( I ) lifespan. WT N2 worms as control in ( D , E , I ); WT N2 worms crossed with unc-25 ::GFP worms to visualize MNs as control in ( F – H ). n = 30 worms for each group. RNAi technology was used to knock down pink-1 and pdr-1 in worm MNs. TU3401 worms expressing SID-1 were crossed to each strain, ensuring gene knockdown within neurons. ( J ) Representative images of mt-Rosella indicated mitophagy in WT N2 worms and SOD1 G93A transgenic worms crossed with mt-Rosella worms and SID-1 worms. The effect of ISO on promoting neuronal mitophagy ( K ) and improving swimming ability ( L ) was inhibited by knockdown of pink-1 and pdr-1 . n = 30 worms for each group. Data are presented as the mean ± SD. Exact P values are reported in Appendix Table . One-way ANOVA followed by Dunnett’s multiple comparisons test in ( C , K , L ). Log-rank (Mantel–Cox) test in ( I ). Two-way ANOVA followed by Tukey’s multiple comparisons test in ( D , E , G , H ). .
Article Snippet:
Techniques: Expressing, Transgenic Assay, Control, Knockdown
Journal: EMBO Molecular Medicine
Article Title: Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy
doi: 10.1038/s44321-025-00323-2
Figure Lengend Snippet: ( A ) Schematic of intranasal administration. Magnified schematic showing the transport of Nano-ISO and Nano-ISO#ICG from olfactory filaments across the cribriform plate into the olfactory bulb and release into the brain. ( B ) Representative IVIS images of the distribution of Nano-ISO#ICG in the brain after a single intranasal administration. ( C ) ISO concentrations in mice within 120 h detected by the UPLC-MS/MS assay. ( D ) The onset of tremor in SOD1 G93A mice was delayed in the Nano-ISO group, n = 12 mice in the Veh group, n = 12 mice in the Nano-ISO group, and n = 9 mice in the Riluzole group. ( E ) The hanging time of the animals in the Nano-ISO group after 4 and 5 weeks of drug administration was longer than that animals in the Veh group. ( F ) Nano-ISO prolonged the lifespan of SOD1 G93A mice compared to the Veh treatment. ( G ) Representative images of ChAT staining showing lumbar MNs of wild-type (WT) mice, Veh-treated SOD1 G93A mice, and Nano-ISO-treated SOD1 G93A mice. The ventral horn of the spinal cord is marked with white dotted lines. Scale bars, 200 μm. ( H ) Quantification of ( G ) showed that the number of ChAT + MNs was significantly increased in the Nano-ISO group. Each point represents the average value of ten images for each mouse, n = 5 mice/group. ( I ) Representative images of microglia and astrocyte activation revealed by Iba-I staining and GFAP staining in WT, Veh group, and Nano-ISO group. Scale bars, 50 μm. ( J ) Quantification of ( I ) showed microglia activation was inhibited in the Nano-ISO group. Each point represents the average value of 10 images for each mouse, n = 5 mice/group. ( K ) Quantification of ( I ) showed astrocyte activation was inhibited in the Nano-ISO group. Each point represents the average value of ten images for each mouse, n = 5 mice/group. ( L ) Representative images of MTCO2 and LAMP2 co-localization levels in lumbar ChAT + MNs. ChAT + motor neurons are marked with white dotted borders. Scale bars, 5 μm. ( M ) Quantification of ( L ) MTCO2 and LAMP2 co-localization using Pearson’s correlation coefficient showed that ISO induced mitophagy in lumbar ChAT + MNs. Each point represents the average value of 10 MNs for each mouse, n = 5 mice/group. ( N ) Representative images of pSer65-Ub protein expression in lumber ChAT + MNs. ChAT + motor neurons are marked with white dotted borders. Scale bars, 5 μm. ( O ) Quantification of ( N ) showed that ISO increased pSer65-Ub protein expression in MNs. Each point represents the average value of ten MNs for each mouse, n = 5 mice/group. ( P ) The ultrastructure of mitochondria was observed using EM. ISO improved mitochondrial morphology (green arrow) and induced mitolysosome-like structures (red arrow) in lumbar MNs. Scale bars, 0.5 μm. Data are presented as the mean ± SD. Exact P values are reported in Appendix Table . One-way ANOVA followed by Dunnett’s multiple comparisons test in ( E , H , J , K , M , O ). Log-rank (Mantel–Cox) test in ( D , F ). .
Article Snippet:
Techniques: Tandem Mass Spectroscopy, Staining, Activation Assay, Expressing
Journal: EMBO Molecular Medicine
Article Title: Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy
doi: 10.1038/s44321-025-00323-2
Figure Lengend Snippet: ( A ) Schematic diagram of electrophysiological test in mice. ( B – D ) Statistical results of the CMAP amplitude of gastrocnemius muscle by stimulating sciatic nerve in SOD1 G93A mouse and WT group on Day 50 ( B ), Day 60 ( C ), and Day 90 ( D ). The maximum CMAP amplitude was noted to decrease significantly in SOD1 G93A mice on day 60, n = 5 mice/group on day 50; n = 6 mice for WT and n = 7 mice for G93A on day 60; n = 3 mice/group on day 90. ( E ) Representative images of microglia and astrocyte activation revealed by Iba-I staining and GFAP staining. Scale bar, 25 μm. ( F ) Representative images of ChAT and NeuN staining. White arrows indicate motor neurons with shrunken cell bodies. Scale bar, 25 μm. ( G , H ) Statistical results of Iba-I staining and GFAP staining in ( E ) demonstrating that both the microglia and astrocyte activation were detected in the ventral horn of lumbar spinal cord of SOD1 G93A mice on day 60. Each point represents the average value of 10 images for each mouse, n = 5 mice/group. ( I , J ) Statistical results of the number of MNs by NeuN staining and ChAT staining. No loss of MNs was detected in the ventral horn of lumbar spinal cord of SOD1 G93A mice on day 60. Each point represents the average value of 10 images for each mouse, n = 5 mice/group. ( K ) Schematic diagram of the exploration of Nano-ISO therapeutic effects in SOD1 G93A mice. Data are presented as the mean ± SD. Exact P values are reported in Appendix Table . Unpaired t test.
Article Snippet:
Techniques: Activation Assay, Staining
Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
Article Title: Expanding axonal transcriptome brings new functions for axonally-synthesized proteins in health and disease
doi: 10.1177/1073858417712668
Figure Lengend Snippet: Axonal Transcriptome Profiles
Article Snippet: The reader should bear in mind that this is a rapidly evolving area and additional diseases and/or disease mechanisms linked to axonal protein synthesis will undoubtedly be uncovered in the near future. table ft1 table-wrap mode="anchored" t5 caption a7 Disease/Disorder mRNAs Altered Mechanism References Alzheimer disease ATF4 Aβ1-42 induced transcription and anterograde transport ( Baleriola and others 2014 ) Amyotrophic lateral sclerosis (ALS) Nefl Decreased transport with TDP-43 mutation ( Alami and others 2014 ) 271 decreased + 176 increased Altered axonal localization with TDP-43 A315T expression (
Techniques: Microarray, Cell Differentiation, Transduction, Knockdown, RNA Binding Assay, RNA Sequencing, Expressing, Control, Binding Assay
Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
Article Title: Expanding axonal transcriptome brings new functions for axonally-synthesized proteins in health and disease
doi: 10.1177/1073858417712668
Figure Lengend Snippet: A, Where are mRNAs stored in axons? There is clear evidence for storage of mRNAs in axons, where they are somehow sequestered away from the translational machinery and kept dormant until needed. The mechanisms underlying this are not known. How does an RNP disengage from the motor proteins used for transport into axons and avoid translation of its mRNA? Binding of additional proteins to the RNP (1) or replacement of RNP proteins with other RBPs (2) are possible mechanisms. Additionally, there must be stimulus-dependent mechanisms to recruit axonal mRNAs from their storage site (3).
Article Snippet: The reader should bear in mind that this is a rapidly evolving area and additional diseases and/or disease mechanisms linked to axonal protein synthesis will undoubtedly be uncovered in the near future. table ft1 table-wrap mode="anchored" t5 caption a7 Disease/Disorder mRNAs Altered Mechanism References Alzheimer disease ATF4 Aβ1-42 induced transcription and anterograde transport ( Baleriola and others 2014 ) Amyotrophic lateral sclerosis (ALS) Nefl Decreased transport with TDP-43 mutation ( Alami and others 2014 ) 271 decreased + 176 increased Altered axonal localization with TDP-43 A315T expression (
Techniques: Binding Assay
Journal: The Journal of Neuroscience
Article Title: Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS
doi: 10.1523/JNEUROSCI.1470-07.2007
Figure Lengend Snippet: Genes significantly altered at 60 d in motorneurons expressing the G93A SOD1
Article Snippet:
Techniques: Expressing, Membrane, Sequencing, Activity Assay, Binding Assay, Protein Binding, Translocation Assay, Ubiquitin Proteomics, Virus
Journal: The Journal of Neuroscience
Article Title: Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS
doi: 10.1523/JNEUROSCI.1470-07.2007
Figure Lengend Snippet: Q-PCR results. A, Significant upregulation of necdin at 60 d (p = 0.04), which is downregulated at the late stage of the disease (p = 0.003). B, Consistent upregulation of cyclin I throughout the pathology (60 d, p = 0.05; 90 d, p = 0.1; 120 d, p = 0.03). C, Consistent downregulation of plexin domain containing 1 (60 d, p = 0.02; 90 d, p = 0.003; 120 d, p = 0.001). Error bars indicate SD. Tg, Transgenic; N-Tg, nontransgenic. *p ≤ 0.05; **p ≤ 0.01.
Article Snippet:
Techniques: Transgenic Assay
Journal: The Journal of Neuroscience
Article Title: Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS
doi: 10.1523/JNEUROSCI.1470-07.2007
Figure Lengend Snippet: Genes significanlty altered at 90 d in motorneurons expressing the G93A SOD1
Article Snippet:
Techniques: Expressing, Variant Assay, Activity Assay, Membrane
Journal: The Journal of Neuroscience
Article Title: Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS
doi: 10.1523/JNEUROSCI.1470-07.2007
Figure Lengend Snippet: Genes significantly altered at 120 d in motorneurons expressing the G93A SOD1
Article Snippet:
Techniques: Expressing, Binding Assay, Sequencing, Activity Assay, Protein Binding, Transformation Assay, Ubiquitin Proteomics, Activation Assay, Membrane
Journal: The Journal of Neuroscience
Article Title: Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS
doi: 10.1523/JNEUROSCI.1470-07.2007
Figure Lengend Snippet: A, Motor neurons isolated from G93A mice at 60 d show upregulation in several classes of genes delineating what is likely to be happening in these cells under stress. There is upregulation of the transcriptional machinery, along with upregulation of translation-related ribosomal and folding proteins, as the motor neuron attempts to compensate for the ongoing cellular stress. All these mechanisms require ATP, provoking a massive increase in the work load of mitochondria, leading to upregulation of carbohydrate metabolism and respiratory chain activity, which in turn causes increased ROS production. The observed imbalance among the subunits forming the ATP synthase complex, shown by downregulation of the δ subunit, will generate additional oxidative stress, with consequent production of oxidized proteins. These are then ubiquitinated and targeted for proteasomal degradation. B, Over time, the accumulation of damaged proteins and ROS is likely to cause a general collapse in cellular functioning, leading to downregulation of the compensatory pathways previously activated and leaving the cell with decreased energy and protein turnover. The cell increases protein degradation functions, with activation of the lysosomal machinery. Production and secretion of some subunits of the complement cascade are important signals of cellular stress for neighboring cells. The final abortive attempt at survival comes through activation of the cell cycle, with upregulation of cyclin L1 (involved in the transition from the quiescent state, G0, to the first phase of the cell cycle, G1) and cyclins D2 and E2 (involved in the progression of the cell cycle through G1 phase). The upregulation of cyclin I suggests that motor neurons are trying to exercise negative control on the transition between the G1 and S phase to prevent the abnormal progression through the cell cycle. Atf4, Activating transcription factor 4; Atp5a1, ATP synthase F1 complex α1 subunit; Atp5d, ATP synthase F1 complex δ subunit; Cct4, chaperonin subunit 4; Ctsz, cathepsin-Z; Eef1, eukaryotic translation elongation factor 1; Eif3, eukaryotic translation initiation factor 3; Hsp, heat shock protein; Lyz, lysozyme; Lzp-s, P-lysozyme structural; Mdh1, malate dehydrogenase 1; Ndn, necdin; Psmc6, proteasome 26S; Rpl, ribosomal protein L; Sdha, succinate dehydrogenase complex subunit A; Taf9, transcription activator factor 9; Tcerg1, transcription elongation regulator 1 (CA150); Tgfb1i4, transforming growth factor β1-induced transcript 4; Ube1c, ubiquitin-activating enzyme E1C; Uble1b, ubiquitin-like activating enzyme E1B; Usp36, ubiquitin-specific preotease 36; H+, hydrogen ion; TCA, tricarboxylic acid.
Article Snippet:
Techniques: Isolation, Activity Assay, Activation Assay, Negative Control, Ubiquitin Proteomics